D
Blueprint Medicines Corporation BPMC
$87.11 -$2.90-3.22%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 54.96% 57.91% 62.35% 168.80% 30.09%
Total Depreciation and Amortization 161.33% 34.51% 1.09% 30.56% -78.18%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 33.29% -0.33% -6.37% -619.01% -45.11%
Change in Net Operating Assets -197.44% 420.32% 4.54% -63.52% 264.99%
Cash from Operations 62.80% 86.95% 63.16% 17.44% 34.99%
Capital Expenditure 80.06% 99.60% -0.59% 57.28% -215.53%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -58.48% 998.83% -636.46% -55.39% 261.08%
Cash from Investing -57.21% 412.45% -687.20% -55.36% 247.83%
Total Debt Issued 100.00% -100.00% -- -- -218.18%
Total Debt Repaid 100.00% -- -- -- --
Issuance of Common Stock -37.47% 4,163.81% 489.11% -- 521.79%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -37.15% -81.32% 3,259.98% -- 523.36%
Foreign Exchange rate Adjustments -371.87% 209.24% -152.54% -173.60% 1.88%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -19.40% 317.64% 37.26% -15.17% 109.23%
Weiss Ratings